Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

FDA removes black box warnings for most MHT products, reflecting evidence that breast cancer risk varies by formulation, ...

Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

In a small pilot study of patients with advanced pancreatic cancer, early access to medical cannabis shows promise in the ...

Kidney research reveals a complex picture of life-saving treatments that show genuine promise but deliver frustratingly mixed ...

The JASMINE trial showed nipocalimab's efficacy in SLE, meeting primary and secondary endpoints, including steroid sparing ...

Even as India is seeing a rapid rise in childhood obesity, diabetes, and heart-disease risk, a new study showed how ...

Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...

A clinical trial published in the journal Nutrients finds that a single dose of cannabidiol (CBD) can help runners feel ...